Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Tax-Provision" stands at 0.6856 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025.
Sino Biopharmaceutical Ltd's second quarter result of 0.4907 Billion HKD for the item "Tax Provision" represents no change compared to it's first quarter result.
Also, Sino Biopharmaceutical Ltd's second quarter result of 0.4907 Billion HKD for the item "Tax Provision" represents a decrease of -14.17 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sino Biopharmaceutical Ltd's second quarter result of 0.6856 Billion HKD for the item "Tax Provision" represents a decrease of -10.57 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -38.79 percent compared to the value the year prior.
The 1 year change in percent is -38.79.
The 3 year change in percent is -78.06.
The 5 year change in percent is -29.87.
The 10 year change in percent is 81.06.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Tax Provision | 905,699,262,464.00 |
![]() | Johnson & Johnson - Tax Provision | 486,508,953,600.00 |
![]() | AbbVie Inc - Tax Provision | 399,570,305,024.00 |
![]() | Roche Holding AG - Tax Provision | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Tax Provision | 280,205,508,085.11 |